Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs

Extramedullary disease is relatively frequent in multiple myeloma, but our knowledge on the subject is limited and mainly relies on small case series or single center experiences. Little is known regarding the role of new drugs in this setting. We performed a meta-analysis of eight trials focused on...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Haematologica
المؤلفون الرئيسيون:	Vittorio Montefusco, Francesca Gay, Stefano Spada, Lorenzo De Paoli, Francesco Di Raimondo, Rossella Ribolla, Caterina Musolino, Francesca Patriarca, Pellegrino Musto, Piero Galieni, Stelvio Ballanti, Chiara Nozzoli, Nicola Cascavilla, Dina Ben-Yehuda, Arnon Nagler, Roman Hajek, Massimo Offidani, Anna Marina Liberati, Pieter Sonneveld, Michele Cavo, Paolo Corradini, Mario Boccadoro
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Ferrata Storti Foundation 2020-01-01
الوصول للمادة أونلاين:	https://haematologica.org/article/view/9488